NCT00749684 2015-10-19Efficacy and Safety of High-dose Interferon Alfa-2b (Intron A®) for the Adjuvant Treatment of Malignant Melanoma (Study P04083)Merck Sharp & Dohme LLCCompleted138 enrolled 6 charts
NCT00723710 2015-08-26Effect of Proactive Management of Side Effects on Treatment Compliance in Malignant Melanoma Patients on High-dose Intron A Therapy (Study P04600)Merck Sharp & Dohme LLCCompleted299 enrolled 5 charts